Docket #: S21-177
Sparse Gaussian Mixture Model for Learning Gene Regulatory Networks
SparseGMM, is a new algorithm which is a novel statistical approach for identifying drug targets in cancer patients and other diseases by more accurately modeling biological pathways. SparseGMM for the first time allows cancer driver and target genes to be part of multiple modules thanks to a sparse mixture model. This more faithfully models molecular biology and allows to disentangle the multitude of functions of known and unknown genes. With extensive evaluation and testing, we show that SparseGMM identifies more drug target candidates compared to competing methods that we validated using the largest compendium of in vitro data for matched tissues.
Applications
- Drug target discovery for biotech and pharmaceutical companies
Advantages
- Superior in modeling genes with multiple biological functions
- Entropy of a gene can then be used as an indicator of variable biological function
Patents
- Published Application: WO2023097238
Similar Technologies
-
Methods for Diagnosing and Treating Ischemic Eye Disease S21-215Methods for Diagnosing and Treating Ischemic Eye Disease
-
AgeIndex: A Whole-Genome Epigenetic Aging and Rejuvenation Index S21-450AgeIndex: A Whole-Genome Epigenetic Aging and Rejuvenation Index
-
First Report of Small Molecule inhibitors of Histone Acetyltransferase 1 (HAT1) with Anti-Tumor Activity S21-166First Report of Small Molecule inhibitors of Histone Acetyltransferase 1 (HAT1) with Anti-Tumor Activity